• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Insite Vision Inc

+ Add to Watchlist


0.1900 USD 0.0100 5.56%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Insite Vision Inc (INSV)

Open: 0.1650 Day's Range: 0.1650 - 0.2000 Volume: 65,360
Previous Close: 0.1800 52wk Range: 0.1510 - 0.3500 1-Yr Rtn: -38.71%

Stock Chart for INSV

No chart data available.
  • INSV:US 0.1900
  • 1D
  • 1M
  • 1Y
Interactive INSV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INSV

Current P/E Ratio (ttm) 4.2804
Estimated P/E(12/2014) -
Relative P/E vs. SPX 0.2489
Earnings Per Share (USD) (ttm) 0.0444
Est. EPS (USD) (12/2014) -0.1500
Est. PEG Ratio -
Market Cap (M USD) 25.07
Shares Outstanding (M) 131.95
30 Day Average Volume 148,225
Price/Book (mrq) -
Price/Sale (ttm) 0.8134
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INSV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for INSV

InSite Vision Incorporated develops ophthalmic pharmaceutical products based on its DuraSite drug delivery technology. The Company also develops genetically based tools for the diagnosis and prognosis of glaucoma. InSite's products are intended to address a broad spectrum of ocular indications, including glaucoma, inflammation, and infection.

Timothy M RuaneChief Executive OfficerLouis C DrapeauVP/CFO
Lyle M BowmanVP:Development/SecretaryKamran HosseiniVP:Regulatory Affairs
More Company Profile & Key Executives for INSV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil